Loading...
The smooth and bumpy road of trastuzumab administration: from intravenous (IV) in a hospital to subcutaneous (SC) at home
Trastuzumab has become standard of care in the treatment of early and metastatic HER2-positive breast cancer. Initially trastuzumab could only be administered intravenously (IV), however since a few years there is also a subcutaneous (SC) formulation. The efficacy and the safety profile of both form...
Na minha lista:
| Udgivet i: | Facts Views Vis Obgyn |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Universa Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5506771/ https://ncbi.nlm.nih.gov/pubmed/28721185 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|